EUVIMEDEUVIMED entdecken
Crossref

Anti‐Inflammatory Effects of Astragaloside IV–Chitosan Nanoparticles and Associated Anti‐Inflammatory Mechanisms Based on Liquid Chromatography‐Mass Spectrometry Metabolomic Analysis of RAW264.7 Cells

Tingli Qu iD, Shasha Suo, Liqiu Yan, Liwei Wang, Taigang Liang

Chemistry & Biodiversity · 2025

DOI: 10.1002/cbdv.202402234 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Tingli Qu und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Science, Shanxi Medical University, Taiyuan, P. R. China. Hauptthemen laut MEDLINE: Nanoparticles, Saponins, Triterpenes, Chitosan. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Astragaloside IV (ATS) is an active component of Astragalus membranaceus , which has immune regulation and anti‐inflammatory effects. However, owing to its large molecular weight and poor solubility in water, the therapeutic effects of ATS are limited. We aimed to prepare ATS‐chitosan (ATS‐CS) nanoparticles and determine their anti‐inflammatory effect and mechanism of action on RAW264.7 cells using metabolomics. The size of the ATS‐CS nanoparticles was 200.3 nm with a zeta potential of 30.5 mV, and the encapsulation rate and drug loading were 69% and 13%, respectively. ATS‐CS nanoparticles not only significantly decreased the increase of nitric oxide, interleukin‐6, and tumor necrosis factor‐α levels induced by lipopolysaccharide, but also exerted an anti‐inflammatory effect by acting on arginine and proline, glutathione, sphingolipid, glycerophospholipid, glycine, serine, and threonine metabolism. Our findings confirmed that ATS‐CS nanoparticles had good anti‐inflammatory activity and showed that the activity of high molecular weight could be increased by producing nanoparticles. Our study paves the way for exploring the mechanism of nanoparticles through metabolomics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesSaponinsTriterpenesChitosanMetabolomicsAnti-Inflammatory AgentsAnimalsMiceRAW 264.7 CellsLipopolysaccharidesNitric OxideMass SpectrometryTumor Necrosis Factor-alphaChromatography, LiquidParticle SizeInterleukin-6Cell SurvivalLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

RAW264.7 cellsanti‐inflammatory effectastragaloside IV‐chitosan nanoparticleshigh‐performance liquid chromatography‐mass spectrometry metabolomicsmechanism

Substanzen

SaponinsTriterpenesastragaloside AChitosanAnti-Inflammatory AgentsLipopolysaccharidesNitric OxideTumor Necrosis Factor-alphaInterleukin-6

Autor:innen und Institutionen

  • School of Pharmaceutical Science, Shanxi Medical University, Taiyuan, P. R. China.

ORCID-Profile: Tingli Qu

Zitieren

APA

Qu, T., Suo, S., Yan, L., Wang, L., & Liang, T. (2025). Anti‐Inflammatory Effects of Astragaloside IV–Chitosan Nanoparticles and Associated Anti‐Inflammatory Mechanisms Based on Liquid Chromatography‐Mass Spectrometry Metabolomic Analysis of RAW264.7 Cells. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202402234

Vancouver

Qu T, Suo S, Yan L, Wang L, Liang T. Anti‐Inflammatory Effects of Astragaloside IV–Chitosan Nanoparticles and Associated Anti‐Inflammatory Mechanisms Based on Liquid Chromatography‐Mass Spectrometry Metabolomic Analysis of RAW264.7 Cells. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202402234

BibTeX
@article{Qu2025,
  author = {Qu, Tingli and Suo, Shasha and Yan, Liqiu and Wang, Liwei and Liang, Taigang},
  title = {Anti‐Inflammatory Effects of Astragaloside IV–Chitosan Nanoparticles and Associated Anti‐Inflammatory Mechanisms Based on Liquid Chromatography‐Mass Spectrometry Metabolomic Analysis of RAW264.7 Cells},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202402234}
}
Kostenlos starten →